disease – Salmon Science

disease

Hydrogen peroxide treatment of Atlantic salmon temporarily decreases oxygen consumption but has negligible effects on hypoxia tolerance and aerobic performance.

By Romano Studer|2023-04-21T16:11:08+10:00April 20th, 2023|0 Comments

Lipoxygenase enzymes, oligosaccharides (Raffinose and Stachyose) and 11sA4 and A5 globulins of Glycinin present in soybean meal are not drivers of enteritis in juvenile Atlantic salmon (Salmo salar).

By Romano Studer|2023-04-21T16:12:01+10:00April 20th, 2023|0 Comments

Effect of prophylactic treatment with Chloramine-T on gill histology and microbiome of Atlantic Salmon (Salmo salar) under commercial conditions.

By Romano Studer|2023-04-21T16:10:20+10:00April 20th, 2023|0 Comments

Transcriptome response of Atlantic salmon (Salmo salar) to a new piscine orthomyxovirus.

By Romano Studer|2023-04-21T16:14:11+10:00April 20th, 2023|0 Comments

Comparative transcriptome analysis of pilchard orthomyxovirus (POMV) and infectious salmon anaemia virus (ISAV).

By Romano Studer|2023-04-21T16:16:37+10:00April 20th, 2023|0 Comments

Immersion challenge of naïve Atlantic salmon with cultured Nolandella sp. and Pseudoparamoeba sp. did not increase the severity of Neoparamoeba perurans-induced amoebic gill disease (AGD).

By Romano Studer|2023-04-21T16:12:06+10:00April 20th, 2023|0 Comments

A high throughput viability screening method for the marine ectoparasite Neoparamoeba perurans.

By Romano Studer|2023-04-21T16:00:06+10:00April 20th, 2023|0 Comments

TSGA IPA: Establishing viral diagnostics for salmonid aquaculture in Tasmania: characterisation and identification of Salmon Orthomyxo-like virus (SOMV) and associated pathology in Atlantic Salmon

By Romano Studer|2023-04-21T16:15:11+10:00April 20th, 2023|0 Comments

Host-parasite interaction of Atlantic salmon (Salmo salar) and the ectoparasite Neoparamoeba perurans in amoebic gill disease.

By Romano Studer|2023-04-21T16:11:13+10:00April 20th, 2023|0 Comments

Preliminary characterization of Tasmanian Aquareovirus (TSRV) isolates.

By Romano Studer|2023-04-21T16:12:36+10:00April 20th, 2023|0 Comments

Development of an RLO vaccine: Proof-of-Concept to commercial application

By Romano Studer|2023-04-21T16:09:45+10:00April 20th, 2023|0 Comments

Pilchard orthomyxovirus fast-track proof-of-concept vaccine

By Romano Studer|2023-04-21T16:12:41+10:00April 20th, 2023|0 Comments

Liver proteome response of pre-harvest Atlantic salmon following exposure to elevated temperature.

By Romano Studer|2023-04-21T16:11:59+10:00April 20th, 2023|0 Comments

Parasitic isopods Ceratothoa banksii and Nerocila orbignyi of farmed Atlantic salmon and their potential as vectors of Neoparamoeba perurans in Tasmania.

By Romano Studer|2023-04-21T16:12:47+10:00April 20th, 2023|0 Comments

Development of Pilchard orthomyxo virus vaccine for salmonids

By Romano Studer|2023-04-21T16:09:47+10:00April 20th, 2023|0 Comments

Development of a vaccine for cutaneous erosion disease of farmed Atlantic salmon

By Romano Studer|2023-04-21T16:09:43+10:00April 20th, 2023|0 Comments

Tasmanian Aquabirnavirus vaccine development: Towards achieving pan-specific protection of cultured salmonids in Australia using multivalent vaccines

By Romano Studer|2023-04-21T16:14:20+10:00April 20th, 2023|0 Comments

Aquareovirus (TSRV) vaccine development for the Tasmanian salmonid aquaculture industry

By Romano Studer|2023-04-21T16:03:59+10:00April 20th, 2023|0 Comments

Prevalence of six amoeba species colonising the gills of farmed Atlantic salmon with amoebic gill disease (AGD) using qPCR.

By Romano Studer|2023-04-21T16:12:35+10:00April 20th, 2023|0 Comments

Pilchard orthomyxovirus (POMV): A newly emerging Orthomyxovirus isolated from pilchards (Sardinops sagax) and farmed Atlantic salmon (Salmo salar) in Australia.

By Romano Studer|2023-04-21T16:12:43+10:00April 20th, 2023|0 Comments

Seawater transmission and infection dynamics of pilchard orthomyxovirus (POMV) in Atlantic salmon (Salmo salar).

By Romano Studer|2023-04-21T16:13:19+10:00April 20th, 2023|0 Comments

Comparative susceptibility and host responses of endemic fishes and salmonids to amoebic gill disease in Tasmania (Feb 2016) – (PDF File 12.0 MB)

By Romano Studer|2023-04-21T16:17:16+10:00April 20th, 2023|0 Comments

Tassal: Amoeba biology diagnostics and farm management strategies for Amoebic Gill Disease (AGD)

By Romano Studer|2023-04-21T16:14:18+10:00April 20th, 2023|0 Comments

Seafood CRC: disease challenge testing at the Centre of Excellence- Scope for estimating the genetics of resistance

By Romano Studer|2023-04-21T16:13:24+10:00April 20th, 2023|0 Comments

Huon: Design and testing of well-boat bathing systems including the development of full freshwater re-circulation capability, and, the safe and reliable use of hydrogen peroxide treatment in both seawater and reusable freshwater baths for Atlantic Salmon

By Romano Studer|2023-04-21T16:11:10+10:00April 20th, 2023|0 Comments

Atlantic Salmon Aquaculture Subprogram: Rickettsia-like organism vaccine development for the salmonid aquaculture industry

By Romano Studer|2023-04-21T16:19:41+10:00April 20th, 2023|0 Comments

Laboratory evaluation of sample collection methods (organs vs swabs) for Tasmanian salmon reovirus detection in farmed Atlantic salmon, Salmo salar L..

By Romano Studer|2023-04-21T16:12:02+10:00April 20th, 2023|0 Comments

Atlantic Salmon Aquaculture Subprogram: assessment of Orthomyxo-like virus pathogenicity in Atlantic salmon

By Romano Studer|2023-04-21T16:04:41+10:00April 20th, 2023|0 Comments

Atlantic Salmon Aquaculture Subprogram: The effects of AGD on gill function – use of a perfused gill model (Sep 2013) – (PDF File 1.5 MB)

By Romano Studer|2023-04-21T16:19:25+10:00April 20th, 2023|0 Comments

Molecular and culture based characterisation of gastrointestinal tract bacteria of Atlantic salmon (Salmo salar L.) within a commercial mariculture system in south-eastern Tasmania.

By Romano Studer|2023-04-21T16:11:52+10:00April 20th, 2023|0 Comments

Pyrosequencing-based characterization of gastrointestinal bacteria of Atlantic salmon (Salmo salar L.) within a commercial mariculture system.

By Romano Studer|2023-04-21T16:13:41+10:00April 20th, 2023|0 Comments

Atlantic Salmon Aquaculture Subprogram: Culture and cryopreservation of Neoparamoeba perurans (AGD)

By Romano Studer|2023-04-21T16:08:51+10:00April 20th, 2023|0 Comments

Development and application of molecular methods (PCR) for detection of Tasmanian Atlantic salmon reovirus.

By Romano Studer|2023-04-21T16:09:37+10:00April 20th, 2023|0 Comments

The spatial and temporal variation of the distribution and prevalence of Atlantic salmon reovirus (TSRV) infection in Tasmania, Australia.

By Romano Studer|2023-04-21T16:14:13+10:00April 20th, 2023|0 Comments

Molecular characterization of Tasmanian aquabirnaviruses from 1998 to 2013.

By Romano Studer|2023-04-21T16:11:49+10:00April 20th, 2023|0 Comments

TSGA IPA: Comparative susceptibility and host responses of endemic fishes and salmonids affected by amoebic gill disease in Tasmania

By Romano Studer|2023-04-21T16:14:06+10:00April 20th, 2023|0 Comments

Seafood CRC: Amoebic Gill Disease vaccine phase III; Sea-based trials, vaccine refinement and commercialisation

By Romano Studer|2023-04-21T16:13:27+10:00April 20th, 2023|0 Comments

Atlantic Salmon Aquaculture Subprogram: whole genome selection to improve selection efficiency for AGD resistance

By Romano Studer|2023-04-21T16:20:20+10:00April 20th, 2023|0 Comments

Seafood CRC: discovery and manipulation of Neoparamoeba perurans aquaporins as a means to treat amoebic gill disease (AGD)

By Romano Studer|2023-04-21T16:13:26+10:00April 20th, 2023|0 Comments

Aquafin CRC – Atlantic Salmon Aquaculture Subprogram: host-pathogen interactions in Amoebic Gill Disease

By Romano Studer|2023-04-21T16:00:14+10:00April 20th, 2023|0 Comments

Molecular characterisation of Australasian isolates of aquatic birnaviruses.

By Romano Studer|2023-04-21T16:11:51+10:00April 20th, 2023|0 Comments

Aquafin CRC – Atlantic Salmon Aquaculture Subprogram: model development for epidemiology of Amoebic Gill Disease

By Romano Studer|2023-04-21T16:03:53+10:00April 20th, 2023|0 Comments

Aquatic Animal Health Subprogram: development of diagnostic procedures for the detection and identification of Piscirickettsia salmonis

By Romano Studer|2023-04-21T16:04:26+10:00April 20th, 2023|0 Comments

Aquafin CRC – Atlantic Salmon Aquaculture Subprogram – development of a vaccine for amoebic gill disease: genomic and cDNA library screening for antigen discovery

By Romano Studer|2023-04-21T16:00:16+10:00April 20th, 2023|0 Comments

Aquafin CRC – Atlantic Salmon Aquaculture Subprogram: treatment and pathophysiology of Amoebic Gill Disease

By Romano Studer|2023-04-21T16:00:18+10:00April 20th, 2023|0 Comments

Aquatic Animal Health Subprogram: vibrios of Aquatic Animals: development of a national standard diagnostic technology

By Romano Studer|2023-04-21T16:04:31+10:00April 20th, 2023|0 Comments

Aquafin CRC – Atlantic Salmon Aquaculture Subprogram: commercial AGD and salmon health project

By Romano Studer|2023-04-21T16:00:21+10:00April 20th, 2023|0 Comments

Aquafin CRC – Atlantic Salmon Aquaculture Subprogram: use of immunomodulation to improve fish performance in Australian temperate water finfish aquaculture

By Romano Studer|2023-04-21T16:03:58+10:00April 20th, 2023|0 Comments

Aquafin CRC – Atlantic Salmon Aquaculture Subprogram: effects of husbandry on AGD

By Romano Studer|2023-04-21T16:03:48+10:00April 20th, 2023|0 Comments

Aquafin CRC – Atlantic Salmon Aquaculture Subprogram: establishment of challenge for AGD

By Romano Studer|2023-04-21T16:03:51+10:00April 20th, 2023|0 Comments

Aquafin CRC – Atlantic Salmon Aquaculture Subprogram: development of an AGD vaccine: phase II

By Romano Studer|2023-04-21T16:03:43+10:00April 20th, 2023|0 Comments

Aquafin CRC – Atlantic Salmon Aquaculture Subprogram: molecular assessment of resistance to AGD in Atlantic salmon

By Romano Studer|2023-04-21T16:03:54+10:00April 20th, 2023|0 Comments

Detection and abundance of Paramoeba species in the environment

By Romano Studer|2023-04-21T16:20:36+10:00April 20th, 2023|0 Comments

Atlantic Salmon Aquaculture Subprogram: effective treatments for the control of amoebic gill disease

By Romano Studer|2023-04-21T16:08:53+10:00April 20th, 2023|0 Comments

Aquatic Animal health Subprogram: production of AQUAVETPLAN disease strategy manual for viral haemorrhagic septicaemia

By Romano Studer|2023-04-21T16:04:28+10:00April 20th, 2023|0 Comments

Aquatic Animal Health Subprogram: whirling disease a disease strategy manual

By Romano Studer|2023-04-21T16:04:33+10:00April 20th, 2023|0 Comments

Atlantic Salmon Aquaculture Subprogram: Hydrogen peroxide treatment of Atlantic salmon affected by AGD

By Romano Studer|2023-04-21T16:09:02+10:00April 20th, 2023|0 Comments

Atlantic Salmon Aquaculture Subprogram: extension funding application- AGD Vaccine phase III

By Romano Studer|2023-04-21T16:08:57+10:00April 20th, 2023|0 Comments

Atlantic Salmon Aquaculture Subprogram: characterisation of EST03G12 and elucidation of its role in Amoebic Gill Disease (AGD) severity

By Romano Studer|2023-04-21T16:08:48+10:00April 20th, 2023|0 Comments

Atlantic Salmon Aquaculture Subprogram: The effects of AGD on gill function – use of a perfused gill model

By Romano Studer|2023-04-21T16:21:14+10:00April 20th, 2023|0 Comments

Genetic variation of handling resilience of Tasmanian Atlantic salmon affected by amoebic gill disease (AGD). In: Susanne Hermesch, Sonja Dominik, editor/s. Breeding Focus 2014 – Improving resilience.

By Romano Studer|2023-04-21T16:11:16+10:00April 20th, 2023|0 Comments

Seafood CRC: genetic selection for Amoebic Gill Disease (AGD) resilience in the Tasmanian Atlantic salmon (Salmo salar) breeding program

By Romano Studer|2023-04-21T16:13:22+10:00April 20th, 2023|0 Comments

Comparative proteomic profiling of newly acquired, virulent and attenuated Neoparamoeba perurans proteins associated with amoebic gill disease.

By Romano Studer|2023-04-21T16:21:35+10:00April 20th, 2023|0 Comments